Jay Flatley

Type: Person

Name: Jay Flatley

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Illumina to Webcast Live Presentation at Upcoming Investment Conferences

Illumina, Inc. announced that it will webcast the Company's presentation at three upcoming investment conferences. In a release, the Company noted event details:Illumina will webcast its presentation at the Robert W. Baird Growth Stock Conference in Chicago, ... [Published Individual.com - May 06 2013]

Entities: Illumina Inc, Genomic Solutions Incorporated, Christian Henry, Jay Flatley

First reported May 03 2013 - Updated May 03 2013 - 1 reports

Illumina Names Charles Dadswell as Senior Vice President and General Counsel

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Illumina, Inc. (NASDAQ:ILMN) announced it has appointed Charles Dadswell as Senior Vice President and General Counsel. Dadswell will assume all functional responsibilities previously ... [Published NewsRX - May 03 2013]

Entities: Illumina Inc, Intellectual Property, Jay Flatley

First reported May 03 2013 - Updated May 03 2013 - 2 reports

Illumina reports net loss for Q1

10 minutes ago, 1:07am (ET) 05/03/2013 DatamonitorIllumina, Inc., a provider of life science tools and integrated systems for the analysis of genetic variation and function, has reported that net loss for the first quarter ended March 31, 2013 was $22.59 ... [Published Zecco - May 03 2013]

Entities: Illumina Inc, Jay Flatley, Gross Profit Margin, Total Revenue, Life Science

First reported Apr 25 2013 - Updated Apr 25 2013 - 1 reports

Illumina Posts Results for Fiscal Year 2013

Illumina, Inc. announced its financial results for the first quarter of 2013. In a release on April 22, the Company noted first quarter 2013 results:-Revenue of $331 million, a 21 percent increase compared to $273 million in the first quarter of 2012-GAAP ... [Published Individual.com - Apr 25 2013]

Entities: Illumina Inc, Patent Litigation, Research & Development, Fiscal Year

First reported Apr 25 2013 - Updated Apr 25 2013 - 2 reports

GlaxoSmithKline plc

Illumina Appoints Charles Dadswell as Senior Vice President and General Counsel

Illumina, Inc. announced it has appointed Charles Dadswell as Senior Vice President and General Counsel. According to a release, Dadswell will assume all functional responsibilities previously held by Christian Cabou, who has retired, and will have worldwide ... [Published Individual.com - Apr 25 2013]

Entities: Illumina Inc, Intellectual Property, Appointed, GlaxoSmithKline plc, bioMérieux SA

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Illumina Inc

Patent suit loss tanks Illumina's strong sales quarter

Illumina ($ILMN) put up another stellar revenue quarter, pulling in $331 million, a 21% jump over last year. But last month's lost patent suit to Syntrix Biosystems tacked on a $106.9 million charge, leaving the sequencing heavyweight with a $23 million ... [Published FiercePharma - Apr 23 2013]

Entities: Illumina Inc, Patent, Jay Flatley

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Illumina Posts Q1 Loss On Charges, But Tops View; Shares Up

Illumina Inc. (ILMN: Quote), Monday posted a loss for the first quarter from a profit a year ago, hurt largely by a hefty litigation payment. Nevertheless, adjusted earnings for the period improved driven mainly by a 21 percent revenue growth. Shares ... [Published RTTNews.com - Apr 23 2013]

Entities: Illumina Inc, Jay Flatley, Litigation, Patent

First reported Apr 18 2013 - Updated Apr 19 2013 - 1 reports

Illumina Partnership Eyes Expanded Presence in China

Illumina will see expanded use of its technologies in China through a new partnership with a Chinese provider of diagnostic testing services used by hospitals and physicians in every province of the mainland, the companies said today. The value of the ... [Published Genetic Engineering News - Apr 18 2013]

Entities: Illumina Inc, China, Assay, Polymerase Chain Reaction, Reagent

First reported Jan 28 2013 - Updated Jan 28 2013 - 1 reports

Illumina Earnings: Strong Performance

Illumina Inc. ( NASDAQ:ILMN ) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are down 1.20%. Markets are at ... [Published Wall St. Cheat Sheet - Jan 28 2013]

Entities: Illumina Inc, Net Income, Jay Flatley

Quotes

...ntellectual property and legal issues facing innovative health care companies," said Jay Flatley, President and Chief Executive Officer of Illumina. "we are... we're a pay-per-view site for premium content. if you'd like to purchase this article, it's only $3."

Illumina Names Charles Dadswell as Senior Vice President and General Counsel [Published NewsRX - May 03 2013]

Jay Flatley, Illumina's President and CEO, said: "we are pleased with our first quarter results. our business demonstrated strong growth across the entire portfolio, which resulted in record revenue, and we made significant progress on furthering our reproductive health strategy with the closing of the verinata acquisition. we are now focused on continuing to deliver on our 2013 strategic initiatives for strong long-term growth."

Illumina reports net loss for Q1 [Published Zecco - May 03 2013]

...ntellectual property and legal issues facing innovative health care companies," said Jay Flatley, President and Chief Executive Officer of Illumina. "we are excited to welcome him to the team and value the expertise he brings as illumina continues to grow."

Illumina Appoints Charles Dadswell as Senior Vice President and General Counsel [Published Individual.com - Apr 25 2013]

...progress on furthering our reproductive health strategy with the closing of the Verinata acquisition," CEO Jay Flatley said in a statement. "we are now focused on continuing to deliver on our 2013 strategic initiatives for strong long-term growth."

Patent suit loss tanks Illumina's strong sales quarter [Published FiercePharma - Apr 23 2013]

More Content

sort by: Date \| Relevance
Your life decoded [Published Argus Leader - May 19 2013]
Illumina to Webcast Live Presentation at Upcomi... [Published Individual.com - May 06 2013]
Illumina Names Charles Dadswell as Senior Vice ... [Published NewsRX - May 03 2013]
Illumina reports net loss for Q1 [Published Zecco - May 03 2013]
Illumina reports net loss for Q1 [Published Zecco - May 03 2013]
ILLUMINA, INC.: Illumina to Webcast Live Presen... [Published 4 Traders - May 01 2013]
Illumina to Webcast Live Presentation at Upcomi... [Published Business Wire - May 01 2013]
Six Reasons Why Illumina Has Nothing to Fear fr... [Published Xconomy - Apr 29 2013]
Illumina Posts Results for Fiscal Year 2013 [Published Individual.com - Apr 25 2013]
Illumina Appoints Charles Dadswell as Senior Vi... [Published Individual.com - Apr 25 2013]
Illumina Taps Charles Dadswell as SVP and Gener... [Published Individual.com - Apr 25 2013]
Four Lessons From IBM And Roche's Failed DNA Co... [Published Forbes.com - Apr 23 2013]
Patent suit loss tanks Illumina's strong sales ... [Published FiercePharma - Apr 23 2013]
Illumina Posts Q1 Loss On Charges, But Tops Vie... [Published RTTNews.com - Apr 23 2013]
Illumina Earnings: Here’s Why Investors are Hap... [Published Wall St. Cheat Sheet - Apr 22 2013]
Illumina Reports Strong Start to Fiscal Year 2013 [Published Street Insider - Apr 22 2013]
Illumina Names Charles Dadswell as Senior Vice ... [Published BioPortfolio - Apr 22 2013]
Illumina Reports Strong Start to Fiscal Year 2013 [Published Scottrade - Apr 22 2013]
Illumina Partnership Eyes Expanded Presence in ... [Published Genetic Engineering News - Apr 18 2013]
Illumina to Announce First Quarter 2013 Financi... [Published Business Wire Science: Science News - Apr 08 2013]
Illumina to Announce First Quarter 2013 Financi... [Published Business Wire Health News - Apr 08 2013]
Local biotech inventor gets $95M verdict in pat... [Published Seattle Times - Mar 16 2013]
Illumina Earnings: Strong Performance [Published Wall St. Cheat Sheet - Jan 28 2013]
World: Illumina Announces Recipients of Agricul... [Published ReliefWeb - Latest Updates - Jan 17 2013]
Illumina to Announce Fourth Quarter and Fiscal ... [Published EON Health & Medicine - Jan 15 2013]
Illumina to Announce Fourth Quarter and Fiscal ... [Published Business Wire Science: Science News - Jan 15 2013]
Illumina to Announce Fourth Quarter and Fiscal ... [Published Business Wire Health News - Jan 15 2013]
Illumina Will Pay $350M for Verinata Health [Published PE Hub News - Jan 07 2013]
Illumina to Webcast Live Presentation at the J.... [Published EON Health & Medicine - Jan 02 2013]
Illumina to Webcast Live Presentation at the J.... [Published Business Wire Health News - Jan 02 2013]